Document is current
Any future updates will be listed below
-
Authors
Pepe, Alessia https://orcid.org/0000-0001-6401-3829
Rizzo, Michele
Galimberti, Sara
Baratè, Claudia
Oliva, Esther Natalie
Arcioni, Francesco
Storti, Sergio
Renne, Stefania
Midiri, Massimo
Restaino, Gennaro
Positano, Vincenzo
Mangione, Maurizio
Meloni, Antonella
-
Funding
Funding for this research was provided by:
The MIOMED project received no-profit support from Novartis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- License Information
-
More Information
Article History
Received: 8 January 2021
Accepted: 11 March 2021
First Online: 19 March 2021
Declarations
:
: The study complied with the Declaration of Helsinki. The institutional review board (Azienda Ospedaliero-Universitaria Pisana) approved this study (protocol number 61494; September 29, 2010).
: All patients gave written informed consent to the protocol.
: AP is the principal investigator of the eMIOT project that receives “no-profit support” from industrial sponsorships (Chiesi Farmaceutici S.p.A., ApoPharma Inc. and Bayer); she is the principal investigator of the MIOMED project that received no-profit support from Novartis. AP and AM received speakers’ honoraria from Chiesi Farmaceutici S.p.A. All the remaining authors have nothing to declare.
